Browse drugs

…s introduced, initially referring to TB resistant to isoniazid, rifampicin, and at least three of the six main classes of second line drug…

… MAE = 1.15 ± 1.80 mg/L, MRE = 11.5 ± 8.6%.Population model for piperacillin-tazobactam: R2 = 0.86, MAE = 9.31 ± 19.33 mg/L, MRE = 38.4 ± 19.5%; after …

…Purpose This study aimed to measure meropenem trough concentrations, assess their association with outcomes, …

…nt de-escalation, which means 32 (39%) completed treatment with meropenem even though a narrower-spectrum antibiotic was effective.Conclu…

…O type (75% vs 93,3% veno-venous), or sampling time relative to meropenem initiation and circuit change. Clinical factors (obesity, mecha…

…t to cephalosporins but susceptible to carbapenems. Intravenous meropenem was commenced, resulting in a rapid clinical improvement within…

…ge and a predominant use of narrow-spectrum antibiotics such as ceftriaxone. The optimisation of antimicrobial use has not negatively affec…

…18%), meropenem (16.8%), and metronidazole (12.4%), followed by ceftriaxone (9.1%).In 2024, 44 meetings were held, reviewing 185 treatments…

… metronidazole (+415.26%), ampicillin/sulbactam (+367.20%), and amikacin (+177.96%), while lowest consumption was observed for oxacillin…

….7), piperacillin 59.15 (22.1–59.4), cefepime 64.8 (29.9–99.7), ceftazidime 59.4 (32.6–73.2); single values: ceftolozane 53.4, aztreonam 36…

…hoalveolar lavage (BAL) culture grew Pseudomonas aeruginosa and meropenem was initiated. He subsequently developed severe thrombocytopeni…

… and a single case of line-related sepsis (6%) was treated with meropenem.Our study showed that short term parenteral nutrition aided nut…